Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes

Journal of Cellular Physiology

Volumn 224, Issue 1, 2010, Pages 120-126

  Heger, J ^a   Schiegnitz, E ^a   Von Waldthausen, D ^a   Anwar, M M ^a   Piper, H M ^b   Euler, G ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN II; GROWTH DIFFERENTIATION FACTOR 15; LY 290042; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE DONOR; OLIGONUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; SMAD PROTEIN; SMAD2 PROTEIN; SNARE PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WORTMANNIN; PROTEIN KINASE INHIBITOR; SMAD1 PROTEIN; SMAD1 PROTEIN, RAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL GROWTH; CELL SIZE; CELL STIMULATION; CELL TRANSFORMATION; CONTROLLED STUDY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; AGE; ANIMAL; CARDIOMEGALY; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HEART VENTRICLE REMODELING; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TIME; WISTAR RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGE FACTORS; ANGIOTENSIN II; ANIMALS; APOPTOSIS; CARDIOMEGALY; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GROWTH DIFFERENTIATION FACTOR 15; MALE; MYOCYTES, CARDIAC; NITRIC OXIDE DONORS; OLIGONUCLEOTIDES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR REMODELING;

EID: 77952522577     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22102     Document Type: Article

References (26)

1. Euler-Taimor G, Heger J. 2006. The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc Res 69:15-25.
2. Godfrey K. 1985. Comparing the means of several groups. N Engl J Med 313:1450-1456.
3. Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, Dixon IM. 1999. Elevation of expression of Smads 2, 3 and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31:667-678.
4. Izumi M, Fujio Y, Kunisada K, Negoro S, Tone E, Funamoto M, Osugi T, Oshima Y, Nakaoka Y, Kishimoto T, Yamauchi-Takihara K, Hirota H. 2001. Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway. J Biol Chem 276:31133-31141.
5. Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, Heineke J, Kotlarz D, Xu J, Molkentin JD, Niessen HW, Drexler H, Wollert KC. 2006. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 98:351-360.
6. Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC. 2007. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 50:1054-1060.
7. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
8. Masaki M, Izumi M, Oshima Y, Nakaoka Y, Kuroda T, Kimura R, Sugiyama S, Terai K, Kitakaze M, Yamauchi-Takihara K, Kawase I, Hirota H. 2005. Smad1 protects cardiomyocytes from ischemia-reperfusion injury. Circulation 111:2752-2759.
9. Pinson A, Schlüter KD, Zhou XJ, Schwartz P, Kessler-Icekson G, Piper HM. 1993. α- and β-adrenergic stimulation of protein synthesis in cultured adult ventricular cardiomyocytes. J Mol Cell Cardiol 25:477-490.
10. Piper HM, Probst I, Hütter JF, Spiekermann PG. 1982. Culturing of calcium stable adult cardiac myocytes. J Mol Cell Cardiol 14:397-412.
11. Rosenkranz S. 2004. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63:423-432.
12. Ruf S, Piper M, Schlüter KD. 2002. Specific role for the extracellular signal-regulated kinase pathway in angiotensin II- but not phenylephrine-induced cardiac hypertrophy in vitro. Pflügers Arch 443:483-490.
13. Schäfer M, Pönicke K, Heinroth-Hoffmann I, Brodde OE, Piper HM, Schlüter KD. 2001. β-Adrenoceptor stimulation attenuates the hypertrophic effect of α-adrenoceptor stimulation in adult rat ventricular cardiomyocytes. J Am Coll Cardiol 37:300-307.
14. Schlüter KD, Goldberg Y, Taimor G, Schäfer M, Piper HM. 1998. Role of phosphatidylinositol 3-kinase activation in the hypertrophic growth of adult ventricular cardiomyocytes. Cardiovasc Res 40:174-181.
15. Schlüter KD, Simm A, Schäfer M, Taimor G, Piper HM. 1999. Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy. Am J Physiol 276:H1655-H1663. (Pubitemid 29246554)
16. Schneiders D, Heger J, Best P, Piper HM, Taimor G. 2005. SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes. Cardiovasc Res 67:87-96.
17. Schröder D, Heger J, Piper HM, Euler G. 2006. Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat. J Mol Med 84:975-983.
18. Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, Fowke PJ, Bass JJ. 1999. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 180:1-9.
19. Sugimori K, Matsui K, Motomura H, Tokoro T, Wang J, Higa S, Kimura T, Kitajima I. 2005. BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. J Bone Miner Metab 23:411-419.
20. Taimor G, Rakow A, Piper HM. 2001. Transcription activator protein 1 (AP-1) mediates NO-induced apoptosis of adult cardiomyocytes. FASEB J 15:2518-2520.
21. Wang J, Xu N, Feng X, Hou N, Zhang J, Cheng X, Chen Y, Zhang Y, Yang X. 2005. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ Res 97:821-828. (Pubitemid 41447133)
22. Wildhirt SM, Suzuki H, Horstman D, Weismüller S, Dudek RR, Akiyama K, Reichart B. 1997. Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction. Circulation 96:1616-1623. (Pubitemid 27375361)
23. Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N, Lindahl B, Horn-Wichmann R, Brabant G, Simoons ML, Armstrong PW, Califf RM, Drexler H, Wallentin L. 2007. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 115:962-971.
24. Xiao XH, Allen DG. 2003. The role of endogenous angiotensin II in ischaemia, reperfusion and preconditioning of the isolated rat heart. Pflügers Arch 445:643-650. (Pubitemid 36403355)
25. Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD. 2006. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 98:342-350.
26. Yndestad A, Ueland T, Oie E, Florholmen G, Halvorsen B, Attramadal H, Simonsen S, Frøland SS, Gullestad L, Christensen G, Damås JK, Aukrust P. 2004. Elevated levels of activin A in heart failure: Potential role in myocardial remodeling. Circulation 109: 1379-1385.